295 related articles for article (PubMed ID: 19278006)
21. Characterization of drug-protein binding process by employing equilibrium sampling through hollow-fiber supported liquid membrane and Bjerrum and Scatchard plots.
Barri T; Trtić-Petrović T; Karlsson M; Jönsson JA
J Pharm Biomed Anal; 2008 Sep; 48(1):49-56. PubMed ID: 18565712
[TBL] [Abstract][Full Text] [Related]
22. Analysis of drug-protein binding using on-line immunoextraction and high-performance affinity microcolumns: Studies with normal and glycated human serum albumin.
Matsuda R; Jobe D; Beyersdorf J; Hage DS
J Chromatogr A; 2015 Oct; 1416():112-20. PubMed ID: 26381571
[TBL] [Abstract][Full Text] [Related]
23. Characterization of solution-phase drug-protein interactions by ultrafast affinity extraction.
Beeram SR; Zheng X; Suh K; Hage DS
Methods; 2018 Aug; 146():46-57. PubMed ID: 29510250
[TBL] [Abstract][Full Text] [Related]
24. Simultaneous high-throughput determination of interaction kinetics for drugs and cyclodextrins by high performance affinity chromatography with mass spectrometry detection.
Wang C; Wang X; Xu X; Liu B; Xu X; Sun L; Li H; Zhang J
Anal Chim Acta; 2016 Feb; 909():75-83. PubMed ID: 26851087
[TBL] [Abstract][Full Text] [Related]
25. Evidence for binding of certain acidic drugs to alpha 1-acid glycoprotein.
Urien S; Albengres E; Zini R; Tillement JP
Biochem Pharmacol; 1982 Nov; 31(22):3687-9. PubMed ID: 7181952
[TBL] [Abstract][Full Text] [Related]
26. Analysis of drug-protein interactions by high-performance affinity chromatography: interactions of sulfonylurea drugs with normal and glycated human serum albumin.
Matsuda R; Anguizola J; Hoy KS; Hage DS
Methods Mol Biol; 2015; 1286():255-77. PubMed ID: 25749961
[TBL] [Abstract][Full Text] [Related]
27. Characterization of the binding of sulfonylurea drugs to HSA by high-performance affinity chromatography.
Joseph KS; Hage DS
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jun; 878(19):1590-8. PubMed ID: 20435530
[TBL] [Abstract][Full Text] [Related]
28. Immobilization of alpha(1)-acid glycoprotein for chromatographic studies of drug-protein binding.
Xuan H; Hage DS
Anal Biochem; 2005 Nov; 346(2):300-10. PubMed ID: 16225836
[TBL] [Abstract][Full Text] [Related]
29. Drug binding to human serum albumin: abridged review of results obtained with high-performance liquid chromatography and circular dichroism.
Ascoli GA; Domenici E; Bertucci C
Chirality; 2006 Sep; 18(9):667-79. PubMed ID: 16823814
[TBL] [Abstract][Full Text] [Related]
30. Stereoselective binding of chiral drugs to plasma proteins.
Shen Q; Wang L; Zhou H; Jiang HD; Yu LS; Zeng S
Acta Pharmacol Sin; 2013 Aug; 34(8):998-1006. PubMed ID: 23852086
[TBL] [Abstract][Full Text] [Related]
31. [Study on binding of drug to serum protein].
Otagiri M
Yakugaku Zasshi; 2009 Apr; 129(4):413-25. PubMed ID: 19336995
[TBL] [Abstract][Full Text] [Related]
32. High perfomance liquid chromatography in pharmaceutical analyses.
Nikolin B; Imamović B; Medanhodzić-Vuk S; Sober M
Bosn J Basic Med Sci; 2004 May; 4(2):5-9. PubMed ID: 15629016
[TBL] [Abstract][Full Text] [Related]
33. Equilibrium gel filtration to measure plasma protein binding of very highly bound drugs.
Weiss HM; Gatlik E
J Pharm Sci; 2014 Feb; 103(2):752-9. PubMed ID: 24375113
[TBL] [Abstract][Full Text] [Related]
34. Compilation of 222 drugs' plasma protein binding data and guidance for study designs.
Zhang F; Xue J; Shao J; Jia L
Drug Discov Today; 2012 May; 17(9-10):475-85. PubMed ID: 22210121
[TBL] [Abstract][Full Text] [Related]
35. Estimation of the plasma protein binding of drugs by size exclusion chromatography at medium pressure (150 lb in-2: 1-03 MPa).
Morris MJ; Brown JR
J Pharm Pharmacol; 1977 Oct; 29(10):642-4. PubMed ID: 21250
[No Abstract] [Full Text] [Related]
36. Recent advances in chromatographic and electrophoretic methods for the study of drug-protein interactions.
Hage DS; Tweed SA
J Chromatogr B Biomed Sci Appl; 1997 Oct; 699(1-2):499-525. PubMed ID: 9392390
[TBL] [Abstract][Full Text] [Related]
37. Analysis of multi-site drug-protein interactions by high-performance affinity chromatography: Binding by glimepiride to normal or glycated human serum albumin.
Matsuda R; Li Z; Zheng X; Hage DS
J Chromatogr A; 2015 Aug; 1408():133-44. PubMed ID: 26189669
[TBL] [Abstract][Full Text] [Related]
38. Methods of determining plasma and tissue binding of drugs. Pharmacokinetic consequences.
Pacifici GM; Viani A
Clin Pharmacokinet; 1992 Dec; 23(6):449-68. PubMed ID: 1458763
[TBL] [Abstract][Full Text] [Related]
39. Differences in the binding of drugs to plasma proteins from newborn and adult man. I.
Kurz H; Mauser-Ganshorn A; Stickel HH
Eur J Clin Pharmacol; 1977 Jul; 11(6):463-7. PubMed ID: 891592
[TBL] [Abstract][Full Text] [Related]
40. Free drug monitoring.
Chan S; Gerson B
Clin Lab Med; 1987 Jun; 7(2):279-87. PubMed ID: 3301170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
